Skip to content
DefDex

Federal award

ASCEND BIOLOGICS INNOVATIONS, LLC

W91YU008C0027

Contract

Obligated and Ceiling

Obligated (net)
$254,480.96
Ceiling (potential value, not spending)
$254,480.96
Current value
$254,480.96
Gross positive obligations
$432,382.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ASCEND BIOLOGICS INNOVATIONS, LLC · HPL3GYA89F75
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ASCEND BIOLOGICS INNOVATIONS, LLC · HPL3GYA89F75
Awarding agency
Department of War · sub-agency 2100 · office W81K04
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
Q401 · MEDICAL- NURSING
Industry (NAICS)
621399 · OFFICES OF ALL OTHER MISCELLANEOUS HEALTH PRACTITIONERS
PIID
W91YU008C0027
Award type code
D
Actions
11 · Jun 23, 2008 to Sep 19, 2017
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 19, 2017FY2017P00010K−$12,460.99
—
Jun 24, 2013FY2013P00009G$28,642.00
—
Sep 19, 2012FY2012P00008M$0.00
—
Sep 18, 2012FY2012P00007D−$129,373.25
—
May 22, 2012FY2012P00006G$87,759.00
—
Jun 1, 2011FY2011P00005G$84,095.00
—
May 25, 2010FY2010P00004G$80,584.00
—
Feb 12, 2010FY2010P00003D$0.00
—
Nov 9, 2009FY2010P00002D−$36,066.80
—
Mar 26, 2009FY2009P00001G$77,182.00
—
Jun 23, 2008FY20080—$74,120.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.